Viyana Drugs Private Limited - Company Profile

It is a paper private limited company based in Uppal, Telangana, India, established in 2023.
2023 Uppal, Telangana, India Under Process Of Striking Off
Last Updated:
Access Report
About Viyana Drugs Private Limited

Viyana Drugs Private Limited, a under process of striking off private limited company, was established on 29 May 2023 in Uppal, Telangana, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21001TS2023PTC173471. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Its leadership includes Vijay Mohan Reddy Godala (Managing Director), Bollam Venkata Reddy (Whole-Time Director), Anjaiah Venkamasetty (Whole-Time Director). It is based at Plot No. 156, Phase - Iii,, I.D.A., Cherlapally, Uppal, Telangana, 500051.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001TS2023PTC173471

  • Registration Number

    173471

  • Incorporation Date

    29 May 2023

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Under Process Of Striking Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 2 Year, 10 Months
Company report

Viyana Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Viyana Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Viyana Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Vijay Mohan Reddy Godala Managing Director 29 May 2023 Current
Bollam Venkata Reddy Whole-Time Director 29 May 2023 Current
Anjaiah Venkamasetty Whole-Time Director 29 May 2023 Current
Koukuntla Srinivas Reddy Whole-Time Director 29 May 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Viyana Drugs.

Enhance accessibility to Viyana Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Viyana Drugs revenue growth over time
Viyana Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Viyana Drugs?

Unlock access to Viyana Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Viyana Drugs?

Unlock and access historical data on people associated with Viyana Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Viyana Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Viyana Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Viyana Drugs
Recent Activity within the Organization
  • Director Appointment

    Vijay Mohan Reddy Godala was appointed as a Managing Director was appointed as a Managing Director on 29 May 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.

  • Director Appointment

    The activity Bollam Venkata Reddy was appointed as a Whole-time director was appointed as a Whole-time director on 29 May 2023 & has been associated with this company since 2 years 10 months . was completed.

  • Director Appointment

    The activity Anjaiah Venkamasetty was appointed as a Whole-time director was appointed as a Whole-time director on 29 May 2023 & has been associated with this company since 2 years 10 months . was completed.

  • Director Appointment

    Koukuntla Srinivas Reddy was appointed as a Whole-time director was appointed as a Whole-time director on 29 May 2023 & has been associated with this company since 2 years 10 months . was recorded as a recent event.

  • Company Incorporation

    The activity Viyana Drugs Private Limited was registered on 29 May 2023 with Roc Hyderabad & aged 2 years 10 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Viyana Drugs Private Limited?

The CIN of Viyana Drugs Private Limited is U21001TS2023PTC173471.

Where is Viyana Drugs Private Limited headquartered?

Viyana Drugs Private Limited is headquartered at Plot No. 156, Phase - Iii,, I.D.A., Cherlapally, Uppal, Telangana, 500051.

When was Viyana Drugs Private Limited incorporated?

Viyana Drugs Private Limited was incorporated on 29 May 2023.

Who are the current directors of Viyana Drugs Private Limited?

The current directors of Viyana Drugs Private Limited are

What is the primary industry of Viyana Drugs Private Limited?

The primary industry of Viyana Drugs Private Limited is Paper.

Is Viyana Drugs Private Limited a listed company?

Viyana Drugs Private Limited is unlisted.

What is the capital structure of Viyana Drugs Private Limited?

The authorized capital of Viyana Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available